Award
Award #HR0011269E092
Contract for Next-Generation CRISPR Gene Drives to Control Invasive Flies
Buyer
Defense Advanced Research Projects Agency
Award Amount
$682,454.00
Ceiling
$682,454.00
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Nov 19, 2026
Identifier
HR0011269E092
This award represents a definitive contract with Objective Biotechnology, Inc., a biotech firm based in Minneapolis specializing in innovative genetic technologies. The contract involves developing next-generation CRISPR gene drives aimed at sustainable control of invasive fly populations, critical for ecological management and public health. The work includes creating and testing advanced genetic tools to suppress or eliminate harmful insect species, promoting environmental balance. Awarded through a competitive process, this multi-year contract highlights the agency's commitment to leveraging cutting-edge biotechnology for invasive species control. The performance period spans several months in 2026, marking an important step in biotechnological pest management initiatives.
Description
ASSESSOR FEEDBACK PDF NEXT-GENERATION CRISPR GENE DRIVES |!#^FOR SUSTAINABLE CONTROL OF INVASIVE FLIES